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SARS-CoV-2 sequencing 
collaboration in west 
Africa shows best 
practices
Genomic surveillance can track 
pathogen transmission during an 
outbreak, identifying actionable 
genomic variation on the co-
evolution of pathogens with the 
human genome and socioeconomic 
demographics.1 Current data suggest 
that decentralising sequencing 
capacity is beneficial, enabling facilities 
to track local infection dynamics for 
prompt interventions.2 Technology 
has also improved to provide mobile 
sequencing platforms that are easily 
deployable even in resource-limited 
settings. Most importantly, findings 
from genomic surveillance can guide 
authorities to establish the best 
interventions to halt transmission 
among the populace and reduce the 
burden on health systems.3
The Genomics Unit of the Medical 
Research Council, The Gambia 
(MRCG), as part of its programme 
of building partnerships with 
research organisations in west 
Africa, reached out to the Nigerian 
Institute of Medical Research, Nigeria, 
to collaborate on whole-genome 
sequencing of SARS-CoV-2. Since 
2008, the Nigerian Institute of Medical 
Research had acquired capacity for 
Sanger sequencing, which was used 
to sequence a fragment and confirm 
the index case of COVID-19 in Nigeria. 
However, this method is not cost-
effective for genomic surveillance 
compared with next-generation 
sequencing methods. Through special 
government funding for COVID-19 
research, the Nigerian Institute of 
Medical Research procured a next-
generation sequencing platform. 
However, travel restrictions and 
the logistics limitations associated 
with the pandemic delayed delivery, 
installation, training, and next-
generation sequencing use. Thus, 
the collaboration with MRCG was 
timely and welcome, as the Nigerian 
Institute of Medical Research sought 
to build capacity for whole-genome 
sequencing of SARS-CoV-2. The Centre 
for Human Virology and Genomics, 
the Central Research Laboratory at the 
Nigerian Institute of Medical Research, 
and the Genomic Unit at MRCG were 
the key facilities involved.
MRCG proposed whole-genome 
sequencing using Oxford Nanopore 
Technology, suitable for rapid 
deployment in resource-limited 
settings. MRCG trained Nigerian 
Institute of Medical Research staff 
and research interns on the Oxford 
Nanopore Technology workflow from 
May 3 to May 11, 2021. 15 participants 
were trained at the standard four-
room sequencing suite at the Centre 
for Human Virology and Genomics, a 
HIV drug resistance sequencing facility 
recognised by WHO. MRCG provided 
Oxford Nanopore Technology, 
MK1C equipment, reagents, and 
consumables. The MK1C can sequence 
one flow cell per run standalone with 
11–96 samples pooled. It does not 
need an internet connection while 
running, and the facility only provided 
power to the equipment. Its minimal 
size easily fits into the laboratory setup.
Samples were retested to verify their 
cycle threshold values because they can 
vary depending on the test kit used.4 
Three sequencing runs of 24 samples 
each were performed using the Artic 
nCoV-2019 sequencing protocol v3.5 
We could not manage and analyse the 
massive fast5 and fastq data produced. 
The MRCG team performed preliminary 
data analysis and committed to 
building local capacity for data analysis, 
to ensure self-sufficient local teams. 
We tested 45 samples, and the data 
suggest a minimum cycle threshold 
of 30 for samples to sequence 
successfully. Nextclade assigned clades 
to 43 sequences, whereas Pangolin 
assigned lineages to only 29 sequences. 
19 sequences had less than 3000 Ns on 
Nextclade.
Subsequently, a bioinformatics 
workshop was organised at MRCG, 
from June 14 to June 25, 2021, with 
two Nigerian Institute of Medical 
Research staff participating. The first 
week dealt with general bioinformatics 
procedures and software, whereas the 
second week focused on data analysis 
specific to SARS-CoV-2 and the 
Oxford Nanopore Technology reads. 
It covered quality control, trimming 
and filtering data, sequence assembly, 
assembly validation, and variant 
calling. Participants were introduced to 
MRCG’s high-performance computing 
cluster, learning to login using a ssh 
tool, a secure login, and submit data 
for analysis remotely. Participants 
received individual logins for future 
data analysis on the high-performance 
computing cluster. This capacity 
building and access to the high-
performance computing cluster has 
enabled local teams to sequence and 
analyse their data rapidly.
Given the challenge of low internet 
speed across the subregion, the 
Nigerian Institute of Medical Research 
provided a Microsoft computer with 
graphical processing units processors 
running Microsoft Windows 10 
2.6Ghz 9th generation Intel i7 with 
32GB memory RAM and one terabyte 
solid-state drive hard disk. The 
MRCG information technology team 
configured this computer for some 
level of data analysis locally. It was 
great learning to configure the Ubuntu 
operating system, bioinformatics 
tools, and pipelines on the Windows 
substation for Linux (WSL2), utilising 
the graphical processing units 
and Nvidia CUDA tools. With this 
computer, we performed base calling 
on fast5 files skipped in a rush to 
execute three runs on the minION 
during the wet-laboratory training.
This engagement typifies excellent 
South-South collaboration that builds 
local capacity across the west-African 
region, and the choice of Nanopore 
technology was perfect. With its low 
start-up cost, any facility with the basic 
laboratory knowledge, equipment, and 
bioinformatics support can sequence 
and perform genomic surveillance. 
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Prompt action to alleviate identified 
challenges, especially using shared 
facilities, is crucial for success.
The Nigerian Institute of Medical 
Research and MRCG intend to expand 
and affirm their collaboration with 
a memorandum of understanding 
to ensure continuity and long-term 
sustainability. Beyond the pandemic, 
enduring South-South collaborations 
should be encouraged.
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